Watermark

BGB-3111-309

Active, not recruiting

A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-3111-309

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

EudraCT Number Info icon SVG graphic used for tooltips or additional information.

2022-501147-32-00

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20230546

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 75 Years

Accepts Healthy Volunteers? No

No Study Documents

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 75 Years

Accepts Healthy Volunteers? No

No Study Documents